BE744162A
(fr)
*
|
1969-01-16 |
1970-06-15 |
Fuji Photo Film Co Ltd |
Procede d'encapsulage
|
JPS5214234B2
(hu)
*
|
1971-07-30 |
1977-04-20 |
|
|
JPS523342B2
(hu)
*
|
1972-01-26 |
1977-01-27 |
|
|
US3787327A
(en)
*
|
1972-02-22 |
1974-01-22 |
Ncr |
Process for manufacturing minute capsules having polynitrile capsule walls
|
GB1413186A
(en)
*
|
1973-06-27 |
1975-11-12 |
Toyo Jozo Kk |
Process for encapsulation of medicaments
|
JPS52102722A
(en)
*
|
1976-02-24 |
1977-08-29 |
Fuji Photo Film Co Ltd |
Photosensitive material for color photography
|
US4357259A
(en)
*
|
1977-08-01 |
1982-11-02 |
Northwestern University |
Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres
|
US4360376A
(en)
*
|
1978-03-17 |
1982-11-23 |
Pennwalt Corporation |
Microencapsulated trifluralin
|
GB2026862A
(en)
*
|
1978-08-04 |
1980-02-13 |
Robins Co Inc A H |
Filaricide implants containing diethylcarbamazine
|
US4273849A
(en)
*
|
1978-08-11 |
1981-06-16 |
Eastman Kodak Company |
Method of using liquid electrographic developers containing polymeric quaternary salts
|
US4272398A
(en)
*
|
1978-08-17 |
1981-06-09 |
The United States Of America As Represented By The Secretary Of Agriculture |
Microencapsulation process
|
US4229513A
(en)
*
|
1979-05-29 |
1980-10-21 |
Eastman Kodak Company |
Liquid electrographic developers containing polymeric quaternary salts
|
US4363863A
(en)
*
|
1979-12-13 |
1982-12-14 |
Nashua Corporation |
Liquid negative developer compositions for electrostatic copying containing polymeric charge control agent
|
US4398954A
(en)
*
|
1979-12-31 |
1983-08-16 |
The Mead Corporation |
Microcapsular coating composition containing a hydrophobic silica
|
JPS57204031A
(en)
*
|
1981-06-09 |
1982-12-14 |
Ricoh Co Ltd |
Heat development type diazo copying material
|
US4374918A
(en)
*
|
1981-09-16 |
1983-02-22 |
Nashua Corporation |
Thermally stable liquid negative developer
|
JPS58126525A
(ja)
*
|
1982-01-20 |
1983-07-28 |
Konishiroku Photo Ind Co Ltd |
ハロゲン化銀写真感光材料
|
JPS59166966A
(ja)
*
|
1983-03-14 |
1984-09-20 |
Fuji Photo Film Co Ltd |
カプセルトナ−の製造法
|
JPS60100516A
(ja)
*
|
1983-11-04 |
1985-06-04 |
Takeda Chem Ind Ltd |
徐放型マイクロカプセルの製造法
|
EP0190833B1
(en)
*
|
1985-02-07 |
1991-03-27 |
Takeda Chemical Industries, Ltd. |
Method for producing microcapsule
|
GB8519310D0
(en)
*
|
1985-07-31 |
1985-09-04 |
Zyma Sa |
Granular active substances
|
US4722838A
(en)
*
|
1986-05-09 |
1988-02-02 |
E. I. Du Pont De Nemours And Company |
Self-microencapsulating controlled release pesticide compositions
|
USRE35862E
(en)
*
|
1986-08-18 |
1998-07-28 |
Emisphere Technologies, Inc. |
Delivery systems for pharmacological agents encapsulated with proteinoids
|
US5985354A
(en)
|
1995-06-07 |
1999-11-16 |
Brown University Research Foundation |
Preparation of multiwall polymeric microcapsules from hydrophilic polymers
|
US5912017A
(en)
*
|
1987-05-01 |
1999-06-15 |
Massachusetts Institute Of Technology |
Multiwall polymeric microspheres
|
US4861627A
(en)
*
|
1987-05-01 |
1989-08-29 |
Massachusetts Institute Of Technology |
Preparation of multiwall polymeric microcapsules
|
US4784879A
(en)
*
|
1987-07-20 |
1988-11-15 |
Dow Corning Corporation |
Method for preparing a microencapsulated compound of a platinum group metal
|
USRE33749E
(en)
*
|
1987-07-20 |
1991-11-19 |
Dow Corning Corporation |
Storage stable heat curable organosiloxane compositions containing microencapsulated platinum-containing catalysts
|
US6056992A
(en)
*
|
1988-06-02 |
2000-05-02 |
Campbell Soup Company |
Encapsulated additives
|
EP0383536A3
(en)
*
|
1989-02-15 |
1991-10-23 |
Seiko Instruments Inc. |
Thermo-sensitive transfer printing medium
|
US5019400A
(en)
*
|
1989-05-01 |
1991-05-28 |
Enzytech, Inc. |
Very low temperature casting of controlled release microspheres
|
US4945154A
(en)
*
|
1989-07-07 |
1990-07-31 |
Hexcel Corporation |
Densified polyethersulfone
|
US5443841A
(en)
*
|
1992-06-15 |
1995-08-22 |
Emisphere Technologies, Inc. |
Proteinoid microspheres and methods for preparation and use thereof
|
ES2051214B1
(es)
*
|
1992-02-27 |
1994-12-16 |
Quintela Manuel Arturo Lopez |
Procedimiento para la obtencion de nanoparticulas por polimerizacion en microemulsiones.
|
WO1993017668A1
(en)
*
|
1992-03-12 |
1993-09-16 |
Alkermes Controlled Therapeutics, Inc. |
Controlled release acth containing microspheres
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
US5656297A
(en)
*
|
1992-03-12 |
1997-08-12 |
Alkermes Controlled Therapeutics, Incorporated |
Modulated release from biocompatible polymers
|
FR2693905B1
(fr)
*
|
1992-07-27 |
1994-09-02 |
Rhone Merieux |
Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
|
TW333456B
(en)
*
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
US5401516A
(en)
*
|
1992-12-21 |
1995-03-28 |
Emisphere Technologies, Inc. |
Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
|
US5919407A
(en)
*
|
1992-12-28 |
1999-07-06 |
Moore Business Forms, Inc. |
Method for producing microencapsulated adhesive
|
US5453368A
(en)
*
|
1993-08-27 |
1995-09-26 |
Brown University Research Foundation |
Method of encapsulating biological substances in microspheres
|
ES2236700T3
(es)
*
|
1993-11-19 |
2005-07-16 |
Janssen Pharmaceutica N.V. |
1,2-benzazoles microencapsulados.
|
US5650173A
(en)
*
|
1993-11-19 |
1997-07-22 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of biodegradable microparticles containing a biologically active agent
|
CA2474701C
(en)
|
1993-11-19 |
2009-01-27 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of biodegradeable microparticles containing a biologically active agent
|
US5616315A
(en)
*
|
1994-10-13 |
1997-04-01 |
Gillette Canada Inc. |
Particles including degradable material and anti-microbial agent
|
US5660817A
(en)
*
|
1994-11-09 |
1997-08-26 |
Gillette Canada, Inc. |
Desensitizing teeth with degradable particles
|
US6281015B1
(en)
|
1994-12-16 |
2001-08-28 |
Children's Medical Center Corp. |
Localized delivery of factors enhancing survival of transplanted cells
|
US5922253A
(en)
|
1995-05-18 |
1999-07-13 |
Alkermes Controlled Therapeutics, Inc. |
Production scale method of forming microparticles
|
AU710347B2
(en)
*
|
1995-08-31 |
1999-09-16 |
Alkermes Controlled Therapeutics, Inc. |
Composition for sustained release of an agent
|
US5942253A
(en)
*
|
1995-10-12 |
1999-08-24 |
Immunex Corporation |
Prolonged release of GM-CSF
|
WO1997017063A1
(en)
|
1995-11-09 |
1997-05-15 |
Microbiological Research Authority |
Microencapsulated dna for vaccination and gene therapy
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
DE19545257A1
(de)
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
US5792477A
(en)
*
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
PL195763B1
(pl)
*
|
1997-06-30 |
2007-10-31 |
Monsanto Technology Llc |
Kompozycja do kontrolowanego uwalniania zapewniająca środek grzybobójczy roślinie i sposób wytwarzania kompozycji
|
US6194006B1
(en)
*
|
1998-12-30 |
2001-02-27 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of microparticles having a selected release profile
|
US7651703B2
(en)
*
|
1999-10-15 |
2010-01-26 |
Genentech, Inc. |
Injection vehicle for polymer-based formulations
|
US7582311B1
(en)
|
1999-10-15 |
2009-09-01 |
Genentech, Inc. |
Injection vehicle for polymer-based formulations
|
US6495166B1
(en)
|
1999-11-12 |
2002-12-17 |
Alkermes Controlled Therapeutics Inc. |
Apparatus and method for preparing microparticles using in-line solvent extraction
|
US6705757B2
(en)
*
|
1999-11-12 |
2004-03-16 |
Alkermes Controlled Therapeutics, Inc. Ii |
Method and apparatus for preparing microparticles using in-line solvent extraction
|
US6331317B1
(en)
*
|
1999-11-12 |
2001-12-18 |
Alkermes Controlled Therapeutics Ii Inc. |
Apparatus and method for preparing microparticles
|
US20050037086A1
(en)
*
|
1999-11-19 |
2005-02-17 |
Zycos Inc., A Delaware Corporation |
Continuous-flow method for preparing microparticles
|
US20010049375A1
(en)
|
2000-03-15 |
2001-12-06 |
Wolfgang Sadee |
Neutral antagonists and use thereof in treating drug abuse
|
CN1189159C
(zh)
|
2000-05-05 |
2005-02-16 |
欧莱雅 |
含水溶性美容活性组分水性核的微胶囊及含其的组合物
|
US6264987B1
(en)
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
US6306423B1
(en)
|
2000-06-02 |
2001-10-23 |
Allergan Sales, Inc. |
Neurotoxin implant
|
JP2003535122A
(ja)
*
|
2000-06-02 |
2003-11-25 |
ザイコス インク. |
生物活性物質のための送達システム
|
US20050214327A1
(en)
*
|
2000-06-02 |
2005-09-29 |
Allergan, Inc. |
Neurotoxin-containing suppositories and related methods
|
US20040033241A1
(en)
*
|
2000-06-02 |
2004-02-19 |
Allergan, Inc. |
Controlled release botulinum toxin system
|
US20040170665A1
(en)
*
|
2000-06-02 |
2004-09-02 |
Allergan, Inc. |
Intravitreal botulinum toxin implant
|
US6719970B1
(en)
|
2000-07-10 |
2004-04-13 |
Alkermes Controlled Therapeutics, Inc. |
Method of generating cartilage
|
CA2420854C
(en)
*
|
2000-09-01 |
2013-07-30 |
Palmaya Pty Ltd |
Slow release pharmaceutical preparation and method of administering of same
|
US6858634B2
(en)
*
|
2000-09-15 |
2005-02-22 |
Monsanto Technology Llc |
Controlled release formulations and methods for their production and use
|
US6824822B2
(en)
*
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
US6471995B1
(en)
|
2000-09-27 |
2002-10-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Apparatus and method for preparing microparticles using liquid-liquid extraction
|
US6599627B2
(en)
|
2000-12-13 |
2003-07-29 |
Purdue Research Foundation |
Microencapsulation of drugs by solvent exchange
|
US6767637B2
(en)
*
|
2000-12-13 |
2004-07-27 |
Purdue Research Foundation |
Microencapsulation using ultrasonic atomizers
|
CA2432900C
(en)
|
2000-12-21 |
2007-09-11 |
Nektar Therapeutics |
Induced phase transition method for the production of microparticles containing hydrophilic active agents
|
US20020114843A1
(en)
*
|
2000-12-27 |
2002-08-22 |
Ramstack J. Michael |
Preparation of microparticles having improved flowability
|
US20060269602A1
(en)
*
|
2001-04-13 |
2006-11-30 |
Dasch James R |
Method of modifying the release profile of sustained release compositions
|
US6558702B2
(en)
|
2001-04-13 |
2003-05-06 |
Alkermes Controlled Therapeutics, Inc. |
Method of modifying the release profile of sustained release compositions
|
US7691412B2
(en)
*
|
2001-10-10 |
2010-04-06 |
Pierre Fabre Medicament |
Prolonged release biodegradable microspheres and method for preparing same
|
NZ535008A
(en)
*
|
2002-02-08 |
2005-09-30 |
Alkermes Inc |
Polymer-based compositions for sustained release
|
US7157102B1
(en)
|
2002-05-31 |
2007-01-02 |
Biotek, Inc. |
Multi-layered microcapsules and method of preparing same
|
US7041320B1
(en)
|
2002-05-31 |
2006-05-09 |
Biotek, Inc. |
High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
|
WO2004035754A2
(en)
|
2002-10-17 |
2004-04-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Microencapsulation and sustained release of biologically active polypeptides
|
US20040086532A1
(en)
*
|
2002-11-05 |
2004-05-06 |
Allergan, Inc., |
Botulinum toxin formulations for oral administration
|
US20040131662A1
(en)
|
2003-11-12 |
2004-07-08 |
Davidson Robert S. |
Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
|
US20040191302A1
(en)
|
2003-03-28 |
2004-09-30 |
Davidson Robert S. |
Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
|
US9561182B2
(en)
*
|
2003-08-22 |
2017-02-07 |
Cure Pharmaceutical Corporation |
Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
|
US8999372B2
(en)
*
|
2002-11-14 |
2015-04-07 |
Cure Pharmaceutical Corporation |
Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
|
US20040253274A1
(en)
*
|
2003-06-11 |
2004-12-16 |
Allergan, Inc. |
Use of a clostridial toxin to reduce appetite
|
JP2007517912A
(ja)
*
|
2004-01-13 |
2007-07-05 |
バソジェニックス ファーマシューティカルズ, インコーポレイテッド |
心脈管および腎臓の適応症のための制御放出cgrp送達組成物
|
WO2005070444A2
(en)
*
|
2004-01-13 |
2005-08-04 |
Vasogenix Pharmaceuticals, Inc. |
Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
|
CA2552758A1
(en)
*
|
2004-01-13 |
2005-08-04 |
Vasogenix Pharmaceuticals, Inc. |
Methods for treating acute myocardial infarction by administering calcitonin gene related peptide and compositions containing the same
|
US7691381B2
(en)
*
|
2004-04-15 |
2010-04-06 |
Allergan, Inc. |
Stabilized biodegradable neurotoxin implants
|
US20060110423A1
(en)
*
|
2004-04-15 |
2006-05-25 |
Wright Steven G |
Polymer-based sustained release device
|
ES2536235T3
(es)
*
|
2004-04-15 |
2015-05-21 |
Alkermes Pharma Ireland Limited |
Dispositivo polimérico de liberación prolongada
|
US7456254B2
(en)
*
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
EP1749039A1
(en)
*
|
2004-04-23 |
2007-02-07 |
Amgen Inc. |
Low molecular weight polylactic acid polymers
|
WO2005107714A2
(en)
*
|
2004-05-05 |
2005-11-17 |
Alkermes Controlled Therapeutics, Inc. |
Method of forming microparticles that include a bisphosphonate and a polymer
|
EP1679065A1
(en)
*
|
2005-01-07 |
2006-07-12 |
OctoPlus Sciences B.V. |
Controlled release compositions for interferon based on PEGT/PBT block copolymers
|
US20080213593A1
(en)
*
|
2005-01-21 |
2008-09-04 |
President And Fellows Of Harvard College |
Systems And Methods For Forming Fluidic Droplets Encapsulated In Particles Such As Colloidal Particles
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
US9101949B2
(en)
|
2005-08-04 |
2015-08-11 |
Eilaz Babaev |
Ultrasonic atomization and/or seperation system
|
US7896539B2
(en)
|
2005-08-16 |
2011-03-01 |
Bacoustics, Llc |
Ultrasound apparatus and methods for mixing liquids and coating stents
|
CN102274557B
(zh)
|
2006-08-09 |
2014-12-03 |
精达制药公司 |
渗透性递送***和活塞组件
|
EP2131815A4
(en)
*
|
2007-03-22 |
2012-11-07 |
Alkermes Inc |
coacervation
|
WO2008133908A2
(en)
|
2007-04-23 |
2008-11-06 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
US20080317865A1
(en)
*
|
2007-06-20 |
2008-12-25 |
Alkermes, Inc. |
Quench liquids and washing systems for production of microparticles
|
US7780095B2
(en)
*
|
2007-07-13 |
2010-08-24 |
Bacoustics, Llc |
Ultrasound pumping apparatus
|
US7753285B2
(en)
*
|
2007-07-13 |
2010-07-13 |
Bacoustics, Llc |
Echoing ultrasound atomization and/or mixing system
|
EP2214672B1
(en)
|
2007-10-18 |
2012-10-17 |
Aiko Biotechnology |
Combination analgesic employing opioid and neutral antagonist
|
US8748448B2
(en)
|
2007-10-18 |
2014-06-10 |
Aiko Biotechnology |
Combination analgesic employing opioid agonist and neutral antagonist
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
US9283212B2
(en)
|
2009-02-20 |
2016-03-15 |
Palmaya Pty Ltd |
Pharmaceutical preparation and delivery system
|
AU2010298733B2
(en)
|
2009-09-28 |
2014-10-09 |
Intarcia Therapeutics, Inc. |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
CA2987766A1
(en)
|
2015-06-03 |
2016-12-08 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
SG10201913699QA
(en)
|
2016-05-16 |
2020-03-30 |
Intarcia Therapeutics Inc |
Glucagon-receptor selective polypeptides and methods of use thereof
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
US10835580B2
(en)
|
2017-01-03 |
2020-11-17 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
EP4125823A1
(en)
|
2020-03-30 |
2023-02-08 |
Biological E Limited |
Risperidone microspheres, process for their prepartion and uses thereof
|
CN114405421B
(zh)
*
|
2022-03-15 |
2023-03-21 |
北京化工大学 |
一种纤维素纳米纤维气凝胶光热界面水蒸发材料及其制备方法
|